DSXS

DRUG5 trials

Sponsors

Sun Pharmaceutical Industries, Inc.

Conditions

Atopic DermatitisDermatitis, AtopicPlaque PsoriasisScalp Psoriasis

Phase 2

Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis

CompletedNCT02595008

Sun Pharmaceutical Industries, Inc.Dermatitis, Atopic

Start: 2015-08-28End: 2017-08-25Updated: 2018-12-07

Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis

CompletedNCT02601469

Sun Pharmaceutical Industries, Inc.Plaque Psoriasis

Start: 2015-09-04End: 2017-08-25Updated: 2018-12-07

Phase 3

Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis

CompletedNCT02595073

Sun Pharmaceutical Industries, Inc.Atopic Dermatitis

Start: 2015-09-04End: 2017-08-29Updated: 2018-12-07

Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis

CompletedNCT02618759

Sun Pharmaceutical Industries, Inc.Plaque Psoriasis

Start: 2015-08-28End: 2017-08-25Updated: 2018-12-10

Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis

CompletedNCT02932462

Sun Pharmaceutical Industries, Inc.Scalp Psoriasis

Start: 2016-03-31End: 2017-09-29Updated: 2018-12-06